{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T23:05:08Z","timestamp":1696979108839},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10165-009-0174-0","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T09:48:18Z","timestamp":1242035298000},"page":"366-371","source":"Crossref","is-referenced-by-count":1,"title":["Altered peptide ligands regulate type\u00a0II collagen-induced arthritis in mice"],"prefix":"10.1093","volume":"19","author":[{"given":"Ei","family":"Wakamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Yoshiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,5,12]]},"reference":[{"key":"174_CR1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/intimm\/6.6.897","volume":"6","author":"L Struyk","year":"1994","unstructured":"Struyk L, Hawes GE, Dolhain RJ, van Scherpenzeel A, Godthelp B, Breedveld FC, et\u00a0al. Evidence for selective in vivo expansion of synovial tissue-infiltrating CD4+CD45RO+T lymphocyte on the basis of CDR3 diversity. Int Immunol. 1994;6:897\u2013907.","journal-title":"Int Immunol"},{"key":"174_CR2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar89","volume":"2","author":"L Fugger","year":"2000","unstructured":"Fugger L, Svejgaard A. Association of MHC and rheumatoid arthritis. HLA-DR4 and rheumatoid arthritis: studies in mice and human. Arthritis Res Ther. 2000;2:208\u201311.","journal-title":"Arthritis Res Ther"},{"key":"174_CR3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1073\/pnas.86.2.636","volume":"86","author":"M Londei","year":"1989","unstructured":"Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, et\u00a0al. Persistence of collagen type\u00a0II-specific T cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA. 1989;86:636\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"174_CR4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/ard.58.7.446","volume":"58","author":"T Saeki","year":"1999","unstructured":"Saeki T, Kato T, Masuko-Hongo K, Nakamura H, Yoshino S, Nishioka K, et\u00a0al. Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis. 1999;58:446\u201350.","journal-title":"Ann Rheum Dis"},{"key":"174_CR5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2567.2001.01267.x","volume":"103","author":"JA Luross","year":"2001","unstructured":"Luross JA, Williams NA. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology. 2001;103:407\u201316.","journal-title":"Immunology"},{"key":"174_CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0092-8674(92)90139-4","volume":"68","author":"MTD Magistris","year":"1992","unstructured":"Magistris MTD, Alexander J, Coggeshall M, Altman A, Gaeta FC, Grey HM, et\u00a0al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 1992;68:625\u201334.","journal-title":"Cell"},{"key":"174_CR7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1084\/jem.181.4.1569","volume":"181","author":"C Pfeiffer","year":"1995","unstructured":"Pfeiffer C, Stein J, Aouthwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med. 1995;181:1569\u201374.","journal-title":"J Exp Med"},{"key":"174_CR8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/s10165-006-0495-1","volume":"16","author":"Y Ohnishi","year":"2006","unstructured":"Ohnishi Y, Tsutsumi A, Matsumoto I, Goto D, Ito S, Kuwana M, et\u00a0al. Altered peptide ligands control type\u00a0II collagen-reactive T cells from rheumatoid arthritis patients. Mod Rheumatol. 2006;16:226\u20138.","journal-title":"Mod Rheumatol"},{"key":"174_CR9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0092-8674(89)90287-0","volume":"59","author":"DC Wraith","year":"1989","unstructured":"Wraith DC, Smilek DE, Mitchell DJ, Steinman L, McDevitt HO. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 1989;59:247\u201355.","journal-title":"Cell"},{"key":"174_CR10","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.4049\/jimmunol.150.10.4652","volume":"150","author":"LK Myers","year":"1993","unstructured":"Myers LK, Rosloniec EF, Seyer JM, Stuart JM, Kang AH. A synthetic peptide analogue of a determinant of type\u00a0II collagen prevents the onset of collagen-induced arthritis. J Immunol. 1993;150:4652\u20138.","journal-title":"J Immunol"},{"key":"174_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri2153","volume":"7","author":"SD Miller","year":"2007","unstructured":"Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol. 2007;7:665\u201377.","journal-title":"Nat Rev Immunol"},{"key":"174_CR12","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","volume":"171","author":"S Nakae","year":"2003","unstructured":"Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171:6173\u20137.","journal-title":"J Immunol"},{"key":"174_CR13","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.4049\/jimmunol.161.7.3589","volume":"161","author":"LK Myers","year":"1998","unstructured":"Myers LK, Tang B, Rosloniec EF, Stuart JM, Chiang TM, Kang AH. Characterization of a peptide analogue of a determinant of type\u00a0II collagen that suppress collagen-induced arthritis. J Immunol. 1998;161:3589\u201395.","journal-title":"J Immunol"},{"key":"174_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00296-008-0634-4","volume":"29","author":"J Zhao","year":"2008","unstructured":"Zhao J, Li R, He J, Shi J, Long L, Li Z. Mucosal administration of an altered CII263\u2013272 peptide inhibits collagen-induced arthritis by suppression of Th1\/Th17 cells and expansion of regulatory T cells. Rheumatol Int. 2008;29:9\u201316.","journal-title":"Rheumatol Int"},{"key":"174_CR15","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","volume":"158","author":"K Vermeire","year":"1997","unstructured":"Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 1997;158:5507\u201313.","journal-title":"J Immunol"},{"key":"174_CR16","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.4049\/jimmunol.179.4.2300","volume":"179","author":"K Coppieters","year":"2007","unstructured":"Coppieters K, Van Beneden K, Jacques P, Dewint P, Vervloet A, Vander Cruyssen B, et\u00a0al. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in ligand-specific manner. J Immunol. 2007;179:2300\u20139.","journal-title":"J Immunol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-009-0174-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T02:46:14Z","timestamp":1684982774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-009-0174-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1007\/s10165-009-0174-0","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,12]]}}}